Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/ANR stock hub

ASX/ANR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/ANRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/ANR

In the news

Latest news · ASX/ANR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-105.2

P25 -118.7P50 -49.4P75 -1.2

ROIC-65.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/ANR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

AUD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 1.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000ANR0
Last refreshed	2026-05-10
Market cap	AUD 2.8M
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
Sic	2836
Symbol	asx/ANR
Website	https://anataralifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-46.02%
EV Earnings	-1.34x
EV/Sales	2.82x
P/B ratio	2.52x
P/S ratio	4.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-209.05%
EBITDA Margin	-209%
Gross margin	-37.01%
Gross Profit	AUD -230,830
Net Income	AUD -1.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-209.79%
Profit Margin	-209.79%
ROA	-52.81
Roa5y	-62.25
ROCE	-114.6
ROE	-105.2
Roe5y	-133.3
ROIC	-65.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.14%
Cagr1y	50.04%
Cagr3y	-31.63%
Cagr5y	-42.69%
EPS Growth Quarters	2
EPS Growth Years	3
Revenue Growth	-30.27x
Revenue Growth Q	-66.07x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.4
Assets	AUD 1.3M
Cash	AUD 1.1M
Current Assets	AUD 1.3M
Current Liabilities	AUD 188,627
Equity	AUD 1.1M
Interest Coverage	-124.3
Liabilities	AUD 195,915
Long Term Assets	AUD 0
Long Term Liabilities	AUD 7,288
Net Cash	AUD 1.1M
Net Cash By Market Cap	AUD 38.16
Net Cash Growth	-1.5%
Net Debt Equity	AUD -0.96
Tangible Book Value	AUD 1.1M
Tangible Book Value Per Share	AUD 0
WACC	8.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.03
Net Working Capital	AUD 52,291
Quick ratio	6.85
Working Capital	AUD 1.1M
Working Capital Turnover	AUD 0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.18%
1Y total return	50%
200-day SMA	0.01
3Y total return	-68.04%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.81%
All Time High	1.83
All Time High Change	-99.51%
All Time High Date	2017-11-29
All Time Low	0
All Time Low Change	125%
All Time Low Date	2025-05-12
ATR	0
Beta	0.68
Beta1y	0.75
Beta2y	0.44
Ch YTD	-35.71
High	0.01
High52	0.02
High52 Date	2025-09-10
High52ch	-55%
Low	0.01
Low52	0
Low52 Date	2025-06-05
Low52ch	125%
Ma50ch	-19.64%
Price vs 200-day SMA	-10%
RSI	42.78
RSI Monthly	36.87
RSI Weekly	37.97
Sharpe ratio	-0.07x
Sortino ratio	-0.06
Total Return	-22.66%
Tr YTD	-35.71
Tr3m	-10%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -1.3M
Operating margin	-209

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	211,486,333%
Net Borrowing	-7,420
Shares Insiders	16.9%
Shares Institutions	10.36%
Shares Out	315,950,765
Shares Qo Q	13.22%
Shares Yo Y	22.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	882,120.25x
Bv Per Share	0
Ch10y	-99.25
Ch1y	50
Ch3m	-10
Ch3y	-70
Ch5y	-94.38
Ch6m	-30.77
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	328
Dollar Volume	45,417.7
Earnings Date	2026-05-26
EBIT	AUD -1.3M
EBITDA	AUD -1.3M
EPS	AUD -0.01
F Score	3
Financing CF	1,073,899
Fiscal Year End	June
Founded	2,010
Investing CF	50,000
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-21.05%
Ma20	0.01
Ma20ch	-5.26%
Net CF	33,460
Next Earnings Date	2026-05-26
Open	0.01
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	2.52
Relative Volume	5.72x
Revenue	623,759x
SBC By Revenue	13.63x
Share Based Comp	85,013
Tr6m	-30.77%
Volume	5,046,416
Z Score	-15.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/ANR pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ANR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/ANR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.4%

Share of float held by funds and institutions

Insider ownership

+16.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.7%

Negative means the company is buying back shares.

Technical

ASX/ANR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.8

Neutral momentum band

Price vs 200-day MA

-10.0%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/ANR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ANR stock rating?

asx/ANR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ANR analysis?

The full report lives at /stocks/asx/ANR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ANR?

The latest report frames asx/ANR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ANR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.